Cutis Laxa, Autosomal Dominant 2: Unraveling the Genetic Mysteries
Genetic testing clarifies Cutis Laxa, autosomal dominant 2, aiding early diagnosis and personalized care for this rare connective tissue disorder.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Cracking the Code: Understanding Cutis Laxa, Autosomal Recessive, Type 1B
ARCL1B, a rare genetic disorder, benefits from genetic testing by providing accurate diagnoses, informed family planning, and personalized treatment strategies.
Decoding Deafness-encephaloneuropathy-obesity-valvulopathy Syndrome: The Role of Genetic Testing
Explore how genetic testing aids in diagnosing deafness-encephaloneuropathy-obesity-valvulopathy syndrome, guiding personalized treatment and advancing research.
Decoding Desbuquois Dysplasia 2: The Role of Genetic Testing in Early Diagnosis and Management
Explore how genetic testing aids in diagnosing Desbuquois Dysplasia 2, a rare skeletal disorder. Learn about its impact on early intervention and personalized care.
Decoding Developmental and Epileptic Encephalopathy, 13: The Role of Genetic Testing
Explore how genetic testing aids in diagnosing Developmental and Epileptic Encephalopathy 13, guiding treatment through mutation identification and genotype-phenotype correlations.
Decoding Dilated Cardiomyopathy 2B: The Role of Genetic Testing in Diagnosis and Management
Explore the role of genetic testing in diagnosing Dilated Cardiomyopathy 2B. Uncover how dysferlin mutations impact heart health and guide personalized treatment.
Exploring Ehlers-Danlos Syndrome, Kyphoscoliotic and Deafness Type: The Role of Genetic Testing
Uncover the genetic basis of Ehlers-Danlos Syndrome, kyphoscoliotic and deafness type. See how genetic testing aids in early diagnosis, treatment, and family planning.
Enigmatic Encephalopathy-Hypertrophic Cardiomyopathy-Renal Tubular Disease Syndrome: Unlocking Mysteries with Genetic Testing
Explore how genetic testing reveals insights into Encephalopathy-Hypertrophic Cardiomyopathy-Renal Tubular Disease Syndrome, enabling precise diagnosis and personalized treatment.